Revolution Medicines (RVMD) CCO Anthony Mancini Sells Shares

What Happened
Anthony Mancini, Chief Global Commercialization Officer at Revolution Medicines (RVMD), reported the sale of 1,764 shares on 2026-09-18. The shares were sold at $196.94 each, generating proceeds of $347,402. The transaction is reported as an open-market or private sale and is a disposition (sale), which is often routine.

Key Details

• Transaction date: 2026-09-18; Price: $196.94 per share; Shares sold: 1,764; Total proceeds: $347,402.
• Reported filing date (Form 4): 2026-09-22 — filed within the required two-business-day window.
• Footnote: Transaction was made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Transaction code: S (Sale) — reported as "open market or private sale."

Context
A 10b5-1 trading plan allows insiders to prearrange trades and helps avoid questions about trading on nonpublic information; sales under such plans are typically considered routine and do not necessarily indicate a change in outlook. As this is a sale (not a purchase), it generally provides less informational weight about the insider’s confidence in future stock performance.